Publikation
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer
Wissenschaftlicher Artikel/Review - 01.02.2014
Molife L Rhoda, Pelling Katy, Temple Graham, Heath Catherine, Wheatley Duncan, Oommen Nikhil, Thompson Emilda, Jenkins Peter, Hickish Tamas, Pedley Ian, O'Sullivan Joe M, Olmos David, Fong Peter C, Lumsden Graeme, Bloomfield David, Karavasilis Vasilios, Jones Rob J, Omlin Aurelius, de Bono Johann S